Last update 23 Jan 2025

CD6 x Tubulin

Basic Info

Related Targets
CD6Tubulin

Related

2
Drugs associated with CD6 x Tubulin
ATX-101 (Abcon)
Target
CD6 x Tubulin
Mechanism
CD6 inhibitors [+1]
Active Org.
Abcon Therapeutics, Inc.
Originator Org.
Abcon Therapeutics, Inc.
Active Indication
T-Cell Lymphoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
CD6-ADC
Target
CD6 x Tubulin
Mechanism
CD6 inhibitors [+1]
Active Org.
The Cleveland Clinic FoundationThe Cleveland Clinic Foundation
Originator Org.
The Cleveland Clinic FoundationThe Cleveland Clinic Foundation
Active Indication
T-Cell Lymphoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CD6 x Tubulin
Login to view more data
100 Translational Medicine associated with CD6 x Tubulin
Login to view more data
0 Patents (Medical) associated with CD6 x Tubulin
Login to view more data
1
Literatures (Medical) associated with CD6 x Tubulin
01 Sep 1989ImmunologyQ3 · MEDICINE
Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa.
Q3 · MEDICINE

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free